The Official CORMEDIX (CRMD)thread (run up to FDA approval has begun )

ahomeplateslugger

Superstar
Joined
May 1, 2012
Messages
7,869
Reputation
841
Daps
16,365
That's a good look, and what I hear too from a few conversations on yahoo finance... I'm gonna buy into this and the female viagra $PTN when I get a chance..:ehh:

i gotta look into that.

idk why but i bought more of NBEV instead of CRMD a couple of weeks ago. both had a dip but NBEV's purchase of another company makes me believe they have a higher ceiling since they're working to expand into china.
 

funkee

All Star
Joined
May 20, 2012
Messages
5,000
Reputation
280
Daps
7,562
Reppin
Houston, TX
crmd put in work yesterday. i need to double my position next time it drops. long term hope to eventually have 5k shares.
 

newarkhiphop

Moderator
Staff member
Supporter
Joined
Apr 30, 2012
Messages
37,145
Reputation
9,862
Daps
122,117
If it goes over $50 Im selling about half my position and holding the rest for a buyout or partnership

in your honest opinion and based on the research do you think this has the possibility to get to $50? would that be within the next year year or further out?

or is 50 more of a pipe dream with 20 being closer to reality?
 

Tug life

I stay fly like a guillemot
Joined
May 26, 2012
Messages
3,986
Reputation
1,035
Daps
17,417
Reppin
Harlem World
in your honest opinion and based on the research do you think this has the possibility to get to $50? would that be within the next year year or further out?

or is 50 more of a pipe dream with 20 being closer to reality?
I honestly believe it will reach $50 in the next year. Back when we got approval in Europe and anticipation of a partnership it went to like $52. With U.S. approval it will do that easily because of these reasons.

CRMD:
-just joined Russell 2000 index
-low float
-superb P3 trial and P value
-72% better than standard of care
-no safety concerns
-enough cash until Q3 2020
-fast track,QIDP and unmet need
-10.5 years exclusivity
-FDA news any day
-partnership down the road
quoted from Yahoo finance

If this does get approved, it good to understand this is not just a regular drug, it will be the standard of care and is an unmet medical need. Analyst have set a price target of $27 on the high end and $20 mid range. But this is where the price will ultimately settle this DOES NOT account for parabolic spikes. And with a low float it will go parabolic with good news. Were up about $2 in the past week alone just off the Russell addition
 
Last edited:
Top